Vitality Watch

Dossier pubmed preclinical 02-jun-2026
Animal model, organoid, or cell-culture result — not yet human

Osteogenic promotion by naringin through the PI3K/AKT/mTOR pathway-mediated activation of autophagy and inhibition of apoptosis.

Key claim: Naringin promotes osteoblast proliferation, differentiation, and mineralization and improves bone microarchitecture and BMD in ovariectomized mice by activating protective autophagy and inhibiting apoptosis through the PI3K/AKT/mTOR pathway.

Abstract

Osteoporosis is a common age-related metabolic bone disease closely associated with osteoblast dysfunction, abnormal apoptosis, and dysregulated autophagy. Naringin, a dihydroflavonoid compound mainly found in citrus fruits and various traditional Chinese medicinal herbs (e.g., Aurantii Fructus Immaturus and Rhizoma Drynariae), exhibits potential anti-aging and osteoprotective effects; however, its specific mechanism requires systematic elucidation. Network pharmacology analysis revealed that the core targets of naringin are significantly enriched in the PI3K/AKT signaling pathway, as well as pathways related to apoptosis and autophagy. Subsequent in vitro experiments demonstrated that naringin promotes osteoblast proliferation, differentiation, and mineralization; upregulates the expression of osteogenic markers; activates protective autophagy; and inhibits apoptosis. By employing the autophagy inhibitor 3-MA and the PI3K/AKT agonist 740Y-P to modulate PI3K/AKT/mTOR-mediated autophagy, we confirmed that the anti-apoptotic effect of naringin is dependent on the activation of autophagy. In vivo, naringin administration inhibited the excessive activation of the PI3K/AKT/mTOR pathway, enhanced autophagy, suppressed excessive apoptosis, ameliorated bone microarchitecture, and increased bone mineral density in ovariectomized mice. Our findings elucidate the mechanism by which naringin exerts its anti-osteoporotic effects through regulating the balance between autophagy and apoptosis, thereby providing a theoretical basis for developing naringin-based anti-aging strategies for bone protection.

Why this matters

Naringin promotes osteoblast proliferation, differentiation, and mineralization and improves bone microarchitecture and BMD in ovariectomized mice by activating protective autophagy and inhibiting apoptosis through the PI3K/AKT/mTOR pathway.

Source

Link

Briefing card

Osteogenic promotion by naringin through the PI3K/AKT/mTOR pathway-mediated activation of autophagy and inhibition of apoptosis.
Stage: preclinical · pubmed · 02-jun-2026

Naringin promotes osteoblast proliferation, differentiation, and mineralization and improves bone microarchitecture and BMD in ovariectomized mice by activating protective autophagy and inhibiting apoptosis through the PI3K/AKT/mTOR pathway.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.bone.2026.117958

build build 880 · 2bcef25 · 2026-11-18